Recurrent external ophthalmoparesis during hormonal therapy after thyroid ablation. Case report.
We here report the case of a patient who had undergone total thyroid ablation for Graves' disease. After the beginning of oral therapy with 1-thyroxine, she developed a left external ophthalmoparesis that remitted with the discontinuation of the drug and recurred whenever the replacement therapy (1-thyroxine or tri-iodothyronine) was reintroduced.
Ferracci
F
F
Divisione di Neurologia, Ospedale Civile di Belluno, Italy.
Conte
F
F
Marini
B
B
Fassetta
G
G
D000368:Aged; D003131:Combined Modality Therapy; D005260:Female; D006111:Graves Disease / Q000188:drug therapy / Q000601:surgery / Q000628:therapy*; D006801:Humans; D009886:Ophthalmoplegia / Q000139:chemically induced*; D012008:Recurrence; D013961:Thyroid Gland / Q000601:surgery*; D013963:Thyroid Hormones / Q000009:adverse effects* / Q000627:therapeutic use
D013963:Thyroid Hormones